VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
KMTS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.
$26.43$1.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksKMTSQuarterly Cash Flow

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) quarterly cash flow statement — complete operating, investing & financing history

KMTS Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q4'24Q1'22
Cash from Operations-18.37M-18.34M-26.27M-23.7M-18.38M-18.03M-14.95M-11.52M
Operating CF Margin %-74.8%-81.29%-135.64%-137.52%-121.83%-122.54%-148.68%-
Operating CF Growth %0.1%-1.76%--58.54%----
Net Income-34.17M-32.78M-25.83M-51.11M-21.76M-20.62M-22.28M-13.13M
Depreciation & Amortization1.98M2.37M2.03M1.84M1.89M1.87M3.5M75K
Stock-Based Compensation10.11M8.65M4.58M22.31M459K1.12M389K956K
Deferred Taxes00000000
Other Non-Cash Items-1.56M2.71M-1.07M6.72M905K1.03M740K948K
Working Capital Changes5.27M711K-5.98M-3.46M123K-1.43M2.71M-364K
Change in Receivables5M-1.71M-1.78M-2.85M-2.54M-506K-602K0
Change in Inventory596K-136K-460K-766K-1.65M-433K208K0
Change in Payables1.73M524K-2.9M-196K3.58M-2.81M1.62M318K
Cash from Investing-14.92M-7.42M-8.23M-7.76M-4.06M-4.45M-4.16M-1.84M
Capital Expenditures-9.8M-7.26M-8.17M-8.04M-4.06M-4.43M-4.2M-1.84M
CapEx % of Revenue39.9%32.2%42.16%46.68%26.93%30.1%41.78%-
Acquisitions00000000
Investments--------
Other Investing-5.12M-155K-66K283K0-23K42K0
Cash from Financing149.18M-27K-1.88M214.7M-119K-575K12.24M101K
Debt Issued (Net)00000000
Equity Issued (Net)000-1000K001000K0
Dividends Paid-25K00-6K-50K-575K-263K-56K
Share Repurchases00000000
Other Financing149.21M-27K-1.88M239.71M-69K0-1K157K
Net Change in Cash115.9M-25.79M-36.38M183.24M-22.57M-23.05M-6.87M-13.26M
Free Cash Flow-28.16M-25.61M-34.44M-31.74M-22.45M-22.45M-19.15M-13.36M
FCF Margin %-114.71%-113.49%-177.79%-184.2%-148.75%-152.64%-190.46%-
FCF Growth %-25.46%-14.05%--65.77%----
FCF per Share-0.53-0.50-0.67-0.64-0.45-0.45-0.39-0.27
FCF Conversion (FCF/Net Income)0.54x0.56x1.02x0.46x0.85x0.89x0.67x0.88x
Interest Paid000-3.6M1.18M1.23M1.2M0
Taxes Paid000-38K38K000